static encephalopathy of childhood with neurodegeneration in adulthood

Size: px
Start display at page:

Download "static encephalopathy of childhood with neurodegeneration in adulthood"

Transcription

1 De novo mutations in the autophagy gene encoding WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood Hirotomo Saitsu, Taki Nishimura, Kazuhiro Muramatsu, Hirofumi Kodera, Satoko Kumada, Kenji Sugai, Emi Kasai-Yoshida, Noriko Sawaura, Hiroya Nishida, Ai Hoshino, Fukiko Ryujin, Seiichiro Yoshioka, Kiyomi Nishiyama, Yukiko Kondo, Yoshinori Tsurusaki, Mitsuko Nakashima, Noriko Miyake, Hirokazu Arakawa, Mitsuhiro Kato, Noboru Mizushima & Naomichi Matsumoto Supplementary Note Clinical information of subjects Subject 1 A 33-year old woman, who began to walk at 3 years but never acquired speech, developed epileptic seizures at 4 years, which were controlled by carbamazepine. Her neurological status was stable until adolescence, and at 25 years of age, she understood simple words, ate by herself with a spoon, and walked unsupported. Aggressive behaviors such as biting, shouting and stereotyped hand wringing were seen. She was hypotonic, and neither pyramidal nor extrapyramidal signs were evident. However, akinesia and rigidity progressed from the age of 26. She showed cognitive decline and became increasingly withdrawn. Foot dystonia and swallowing disturbance developed from 28 years of age. Mental and motor deterioration progressed and she became bedridden from the age of 30. At 32 years of age, she showed generalized rigidity with

2 flexion contractures and was mute with no purposeful movements. She required tube feeding. Her initial brain magnetic resonance images (MRI) study at 25 years of age showed hypointensity in the globus pallidus (GP) and substantia nigra (SN) on T2-weighted images suggesting iron accumulation, hyperintensity of the SN with a central band of T1 hypointensity on T1-weighted images, and moderate cerebral and mild cerebellar atrophy. There was no T2 hypointensity in the GP with a central anteromedial region of T2 hyperintensity, called the eye-of-the-tiger sign, which was considered characteristic of pantothenate kinase-associated neurodegeneration (PKAN). These MRI findings were characteristic of SENDA. Follow-up MRI studies at age 32 at 1.5-Tesla and 33 at 3.0-Tesla, also showed hypointensity in the GP and SN on T2-weighted images, hyperintensity of the SN with a central band of T1 hypointensity on T1-weighted images, and marked progression in cerebral atrophy with relatively mild cerebellar atrophy (Fig. 2a,f,i at age of 33 years). She was diagnosed with SENDA with clinical and brain MRI findings at 32 years. Ophthalmologic examinations revealed thinning of the retinal nerve fiber layer. Pigmentary retinopathy was not evident. Lactate in the CSF and her urinary organic acid profile were normal. Tau protein in the CSF was elevated. Nerve conduction studies revealed no abnormalities. Mutations in PANK2, PLA2G6, and MAPT were negative. Chromosomal analysis showed a normal karyotype. A video report of this subject will be published very soon 1. Subject 2 A 28-year old woman, who began to walk at 2 years 7 months with wide-based gait, acquired only one word, Hai ( yes in Japanese), in speech. She developed febrile seizures at the age of 6 months with EEG abnormality. She showed some stereotype

3 movements during early childhood such as hand flapping. At 17 years of age, complex partial seizures developed, which were controlled by antiepileptic drugs. Her neurological status developed very slowly until adolescence. She understood simple words, ate by herself with a spoon, and walked unsupported. Aggressive behaviors, such as shouting during the night, were occasionally seen. Neither pyramidal nor extrapyramidal signs were evident. However, freezing gait, akinesia and rigidity progressed from the age of 25 years. Dystonia and swallowing disturbance developed, and mental and motor deterioration progressed. She became wheelchair-dependent from the age of 27. At 28 years of age, she showed generalized rigidity with flexion contractures and no purposeful movements. Her initial MRI study at 25 years of age showed hypointensity in the GP and SN on T2-weighted images suggesting iron accumulation, hyperintensity of the SN with a central band of T1 hypointensity on T1-weighted images, and moderate cerebral and mild cerebellar atrophy (Fig. 2b,g,j). The eye-of-the-tiger sign was not evident. These MRI findings were characteristic of SENDA. Follow-up MRI study at age 27 showed no significant change. She was diagnosed with SENDA with clinical and brain MRI findings at that time. Ophthalmologic examinations revealed bilateral atrophy of the retinal nerve. Pigmentary retinopathy was not evident. At 2 years of age muscle biopsy was performed, revealing no pathological finding. Mutations in PANK2 and PLA2G6 were negative. Subject 3 A 40-year old woman, who began to walk at age of 2 years and 2 months, but never acquired speech, had several febrile seizures during early childhood, but no epilepsy.

4 Her delayed psychomotor status was static until the third decade of life, but frequent falling, progressive gait disturbance, bradykinesia and cognitive decline gradually developed at around 30 years of age. She could not walk unsupported at 32 and became bedridden a year later. Psychiatric symptoms were not seen. At 33 years of age she was mute and showed no purposeful movements. All activities of daily life needed full support, but she could eat and responded with a laugh to some words. She was complicated with constipation as an autonomic symptom. Dystonia, swallowing disturbance and mental deterioration progressed, and she had no response to any commands and no voluntary movements. She required tube feeding at 38 and a tracheostomy at 39. Her initial MRI study at 33 years of age showed hypointensity in the GP and SN on T2-weighted images suggesting iron accumulation, hyperintensity of the SN with a central band of hypointensity, and mild cerebral and cerebellar atrophy. The eye-of-the-tiger sign was not evident. These MRI findings were characteristic of SENDA. Follow-up MRI study at age 39 at 3.0-Tesla, also showed hypointensity in the GP and SN on T2-weighted images, hyperintensity of the SN with a central band of T1 hypointensity on T1-weighted images, and marked progression in cerebral atrophy with relatively mild cerebellar atrophy (Fig. 2c,h). She was diagnosed with SENDA with clinical and brain MRI findings at that time. Pigmentary retinopathy was not evident. Her blood amino acid profile was normal. Nerve conduction studies revealed no abnormalities. Auditory brainstem response (ABR) shows no reaction, even at 100 db. Electrophysiological studies, such as somatosensory evoked potential (SEP), revealed marked prolongation of the peak latencies. Mutations in PANK2 were negative. A detailed description of brain imaging findings have been previously reported 2.

5 Subject 4 A 51-year old woman, who began to walk at 18 months with spastic hemiparesis. She could speak few words and her developmental quotient was 33 at the age of 7 years. Her neurological status was stable until 19 years of age, when motor function and dystonia began to regress gradually. Akinesia and rigidity progressed from the age of 24 years, and she was bedridden 1 year later. Psychiatric symptoms were not observed. Extrapyramidal signs were evident. Swallowing disturbance and flaccid paralysis developed at around 30 years. Moreover, she showed cognitive decline and became increasingly withdrawn. Mental and motor deterioration progressed. She is currently mute, requires tube feeding and has no purposeful movements. All activities of daily life need full support. Her initial MRI study at 27 years of age showed hypointensity in the GP and SN on T2-weighted images suggesting iron accumulation, hyperintensity of the SN with a central band of T1 hypointensity on T1-weighted imanges, and mild cerebral and cerebellar atrophy. The eye-of-the-tiger sign was not evident. These MRI findings were characteristic of SENDA. Follow-up study at age 46 also showed hypointensity in the GP and SN on T2-weighted images, hyperintensity of the SN with a central band of T1 hypointensity on T1-weighted images, and marked progression in cerebral atrophy with relatively mild cerebellar atrophy (Fig. 2d). She was diagnosed with SENDA with clinical and brain MRI findings at 50 years. Nerve conduction studies revealed no abnormalities. Chromosomal analysis showed a normal karyotype. Subject 5 A 33-year old woman, who began to walk at 18 months and acquired a few words, had stable neurological status during childhood, and at 20 years of age she could speak

6 several words, walk unsupported and run, though without stability. However, she had trunk sway, freezing of her gait and walking difficulty at the age of 21 years. Psychiatric symptoms, such as anxiety disorder, were observed. Rigidity and tremor progressed from age 23 years. In addition, she showed cognitive decline and lost the ability to speak. Mental and motor deterioration progressed and she became bedridden from the age of 29 years. She is currently mute, requires tube feeding and has no purposeful movements. All activities of daily life need full support, but she can laugh in response to some words. She had a febrile seizure at 9 months and developed epileptic seizures at 2 years of age, which were controlled by antiepileptic drugs. No further seizures have occurred, despite her medication being stopped at the age of 20 years. Her initial MRI study at 33 years of age showed hypointensity in the GP and SN on T2-weighted images suggesting iron accumulation, hyperintensity of the SN with a central band of T1 hypointensity on T1-weighted images, and remarkable cerebral atrophy with relatively mild cerebellar atrophy (Fig. 2e). The eye-of-the-tiger sign was not evident. She was diagnosed with SENDA with clinical and brain MRI findings at that time. Pigmentary retinopathy was not evident. Chromosomal analysis revealed mos 46,XX,t(17;19)(q12;q13.3)[5] / 46,XX[25]. References 1. Kasai-Yoshida, E. et al. First video report of static encephalopathy of childhood with neurodegeneration in adulthood. Mov Disord (in press). 2. Kimura, Y. et al. MRI, MR spectroscopy, and diffusion tensor imaging findings in patient with static encephalopathy of childhood with neurodegeneration in adulthood (SENDA). Brain Dev online publication, doi:

7 /j.braindev (11 August 2012)

8 Supplementary Figure 1. WDR45 mutations and their transcripts in lymphoblastoid cell lines (LCLs) derived from five subjects. (a-e) Sequence of the PCR products amplified with genomic DNA (upper) and cdna derived from LCLs of five subjects. (a, b) The c.439+1g>t mutation in subject 1 and the c.516g>c mutation in subject 2 caused insertions of 24-bp sequences of intron 7 and 22-bp sequences of intron 8, respectively. Heterozygous mutations were observed in the genomic DNA in all subjects (a-e). However, only the mutant alleles were expressed in LCLs of subjects 1, 2, 4 and 5 (a, b, d, e), while, both the wild-type allele and the mutant allele were expressed in subject 3 (c).

9 Supplementary Figure 2. Quantification of the amount of LC3-II and autophagic flux in LCLs derived from the subjects families. Cells were treated with 20 μm chloroquine in the absence (a,b) or presence (c,d) of 250 nm Torin1 for 2 h. Cell lysates were analyzed by SDS-PAGE and immunoblotting using anti-lc3 and anti-hsp90 antibodies. The band intensity was quantified using Multi Gauge software version 3.0 (Fujifilm, Tokyo, Japan). Relative levels of LC3-II were normalized with that of Hsp90. The percentage was calculated as the ratio to the mean of the unaffected individuals under non-treated condition (a-d). (e) The ratio of LC3-II levels in the presence of chloroquine

10 (CQ) to the absence of CQ under Torin1-treated condition based on the data in (c,d). Data presented as mean ± S.E. (* P < 0.05, unpaired t-test).

11 Supplementary Table 1. Summary of the exome sequencing performance Family members Sample Status # of alignment reads a Mean coverage %_bases_above5 %_bases_above10 Filter passed variants b Rare variants c Subject 1 Affected 91,876, Father Unaffected 74,087, Mother Unaffected 69,836, Sister Unaffected 74,846, Subject 2 Affected 97,136, Father Unaffected 94,549, Mother Unaffected 101,363, Brother Unaffected 99,781, a PCR duplicates were removed. b Variants that passed GATK hand filtering, were absent in dbsnp135 data, and were not located in segmental duplications. c Protein-altering and splicing-affecting variants (including synonymous variants located within 2-bp from an exon-intron border), which were absent in 88 control exomes.

12 Supplementary Table 2. Candidate variants corresponding to de novo events or autosomal recessive model Subject Chr Position Gene Ref Alt Reads (% of mutant allele) Mutation Amino acid Inheritance a Sanger confirmation ,966,991 ZNF292 T C 110/241 (46) c.3644t>c p.ile1215thr Paternal Confirmed ,967,608 ZNF292 C G 117/244 (48) c.4261c>g p.leu1421val Maternal Confirmed ,523,839 LRRK1 C T 80/157 (51) c.368c>t p.pro123leu de novo Confirmed 1 X 48,934,088 WDR45 C A 13/26 (50) c.439+1g>t de novo Confirmed 2 X WDR45 C G 38/69 (55) c.516g>c p.val172val de novo Confirmed a We utilized data from unaffected brother and sister to examine whether candidate de novo or recessive mutations were consistent with segregation within each family.

13 Supplementary Table 3. Summary of X-inactivation analysis Subject 1 Subject 2 Subject 3 Subject 4 Subject 5 HUMARA NI Marked skewing (98:2) Random (78: 22) Skewing (85:15) Marked skewing (97:3) FRAXA NI Marked skewing (99.99:0.01) NI NI NI NI, Non-informative as alleles were homozygous

14 Supplementary Table 4. PCR conditions and primer sequences WDR45 mutation analysis Exons Product Size (bp) Forward primer (5 >3 ) Reverse primer (5 >3 ) Ex GAGGAGGAAATCAGGTGAGGCAGAA GAGGCCAGGAATCCGAGAAATCTG Ex AAGTAGGTTGAGGTCCCTGGGAAGC TTCTTTCCTCATCTCTGCCCCTCTG Ex8-12 a 1274 TCCTCATCCAGCTCTGTCCATTCTG GCTCAGCTCTGCAGTTCTGCCACT a Internal sequencing primers: Ex8-12seq-F, TCTGCGCTTCCAGTGATAAG; Ex8-12seq-R, GTGGGGAGGGGGTACTCA. The PCR reaction is comprised of 40 cycles in the following conditions: 98 C for 10 sec, 64 C for 20 sec, and 68 C for 1 min. RNA analysis Amplicons Product Size (bp) Forward primer (5 >3 ) Reverse primer (5 >3 ) Ex GAGAAGCTGGTGCTGGAGTTCACCT ATTGATCGTGAATGGAGCAGACGAG Ex CTCCATTCACGATCAATGCACATCA TTATCACTGGAAGCGCAGAGGAAGG Ex GGTCGCAATACTTCCAAGAACGTCA GCTCAGCTCTGCAGTTCTGCCACT The PCR reaction is comprised of 35 cycles in the following conditions: 98 C for 10 sec, 64 C for 20 sec, and 68 C for 30 sec. X inactivation analysis Assays Product Size (bp) Forward primer (5 >3 ) FAM-labeled Reverse primer (5 >3 ) HUMARA a 291 CCAGAATCTGTTCCAGAGCGTGC CTCTACGATGGGCTTGGGGAGAAC FRAXA b 223 AGCCCCGCACTTCCACCACCAGCTCCTCCA GCTCAGCTCCGTTTCGGTTTCACTTCCGGT a The PCR reaction is comprised of 35 cycles in the following conditions: 94 C for 20 sec, 65 C for 20 sec, and 72 C for 20 sec. b The PCR reaction is comprised of 40 cycles in the following conditions: 94 C for 10 sec, 54 C for 10 sec, and 72 C for 10 sec.

Identification of a novel in-frame de novo mutation in SPTAN1 in intellectual disability and pontocerebellar atrophy

Identification of a novel in-frame de novo mutation in SPTAN1 in intellectual disability and pontocerebellar atrophy Hamdan et al., Identification of a novel in-frame de novo mutation in SPTAN1 in intellectual disability and pontocerebellar atrophy Supplementary Information Gene screening and bioinformatics PCR primers

More information

Supplemental Data. Biallelic Variants in CNPY3, Encoding. an Endoplasmic Reticulum Chaperone, Cause Early-Onset Epileptic Encephalopathy

Supplemental Data. Biallelic Variants in CNPY3, Encoding. an Endoplasmic Reticulum Chaperone, Cause Early-Onset Epileptic Encephalopathy The American Journal of Human Genetics, Volume 102 Supplemental Data Biallelic Variants in CNPY3, Encoding an Endoplasmic Reticulum Chaperone, Cause Early-Onset Epileptic Encephalopathy Hiroki Mutoh, Mitsuhiro

More information

CHAPTER IV RESULTS Microcephaly General description

CHAPTER IV RESULTS Microcephaly General description 47 CHAPTER IV RESULTS 4.1. Microcephaly 4.1.1. General description This study found that from a previous study of 527 individuals with MR, 48 (23 female and 25 male) unrelated individuals were identified

More information

Clinical Summaries. CLN1 Disease, infantile onset and others

Clinical Summaries. CLN1 Disease, infantile onset and others Clinical Summaries CLN1 Disease, infantile onset and others The gene called CLN1 lies on chromosome 1. CLN1 disease is inherited as an autosomal recessive disorder, which means that both chromosomes carry

More information

Clinical Spectrum and Genetic Mechanism of GLUT1-DS. Yasushi ITO (Tokyo Women s Medical University, Japan)

Clinical Spectrum and Genetic Mechanism of GLUT1-DS. Yasushi ITO (Tokyo Women s Medical University, Japan) Clinical Spectrum and Genetic Mechanism of GLUT1-DS Yasushi ITO (Tokyo Women s Medical University, Japan) Glucose transporter type 1 (GLUT1) deficiency syndrome Mutation in the SLC2A1 / GLUT1 gene Deficiency

More information

variant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still

variant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still 157 Neurological disorders primarily affect and impair the functioning of the brain and/or neurological system. Structural, electrical or metabolic abnormalities in the brain or neurological system can

More information

Overview of Neurodegeneration with Brain Iron Accumulation (NBIA) Disorders

Overview of Neurodegeneration with Brain Iron Accumulation (NBIA) Disorders Overview of Neurodegeneration with Brain Iron Accumulation (NBIA) Disorders What is NBIA? Neurodegeneration with Brain Iron Accumulation is a group of inherited neurological disorders characterized by

More information

JULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology

JULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology JULY 21, 2018 Genetics 101: SCN1A Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology Disclosures: I have no financial interests or relationships to disclose. Objectives 1. Review genetic

More information

Objectives. Genetics and Rett syndrome: As easy as apple pie! Chromosome to gene to protein

Objectives. Genetics and Rett syndrome: As easy as apple pie! Chromosome to gene to protein Genetics and Rett syndrome: As easy as apple pie! Victoria Mok Siu M.D., FRCPC, FCCMG ORSA conference Ottawa April 24, 2016 Objectives Review chromosomes and genes Understand s Explore the reasons behind

More information

Movement disorders in childhood: assessment and diagnosis. Lucinda Carr

Movement disorders in childhood: assessment and diagnosis. Lucinda Carr Movement disorders in childhood: assessment and diagnosis Lucinda Carr Movement disorders in childhood: Assessment Classification Causes Diagnosis Presentation of movement disorders in childhood: Concerns

More information

A CASE OF GIANT AXONAL NEUROPATHY HEMANANTH T SECOND YEAR POST GRADUATE IN PAEDIATRICS INSTITUTE OF SOCIAL PAEDIATRICS GOVERNMENT STANLEY HOSPITAL

A CASE OF GIANT AXONAL NEUROPATHY HEMANANTH T SECOND YEAR POST GRADUATE IN PAEDIATRICS INSTITUTE OF SOCIAL PAEDIATRICS GOVERNMENT STANLEY HOSPITAL A CASE OF GIANT AXONAL NEUROPATHY HEMANANTH T SECOND YEAR POST GRADUATE IN PAEDIATRICS INSTITUTE OF SOCIAL PAEDIATRICS GOVERNMENT STANLEY HOSPITAL CASE HISTORY Nine year old male child Second born Born

More information

This fact sheet describes the condition Fragile X and includes a discussion of the symptoms, causes and available testing.

This fact sheet describes the condition Fragile X and includes a discussion of the symptoms, causes and available testing. 11111 Fact Sheet 54 FRAGILE X SYNDROME This fact sheet describes the condition Fragile X and includes a discussion of the symptoms, causes and available testing. In summary Fragile X is a condition caused

More information

Nature Genetics: doi: /ng Supplementary Figure 1. Brain magnetic resonance imaging in patient 9 at age 3.6 years.

Nature Genetics: doi: /ng Supplementary Figure 1. Brain magnetic resonance imaging in patient 9 at age 3.6 years. Supplementary Figure 1 Brain magnetic resonance imaging in patient 9 at age 3.6 years. (a d) Axial T2-weighted images show a marked degree of ventriculomegaly. Note the diencephalic mesencephalic junction

More information

The coiled-coil domain containing protein CCDC40 is essential for motile cilia function and left-right axis formation

The coiled-coil domain containing protein CCDC40 is essential for motile cilia function and left-right axis formation The coiled-coil domain containing protein CCDC40 is essential for motile cilia function and left-right axis formation Anita Becker-Heck#, Irene Zohn#, Noriko Okabe#, Andrew Pollock#, Kari Baker Lenhart,

More information

Concurrent Practical Session ACMG Classification

Concurrent Practical Session ACMG Classification Variant Effect Prediction Training Course 6-8 November 2017 Prague, Czech Republic Concurrent Practical Session ACMG Classification Andreas Laner / Anna Benet-Pagès 1 Content 1. Background... 3 2. Aim

More information

Pedigree Analysis. Genetic disorders. Dominant inheritance. Recessive inheritance. Autosomal vs. sex-linked traits. X-linked recessive inheritance

Pedigree Analysis. Genetic disorders. Dominant inheritance. Recessive inheritance. Autosomal vs. sex-linked traits. X-linked recessive inheritance Genetic disorders 4.2 Errors During Meiosis 5.3 Following Patterns of Human nheritance Pedigree Analysis 2005 Lee Bardwell Autosomal vs. sex-linked traits Autosomal traits are caused by genes on autosomes

More information

The Organism as a system

The Organism as a system The Organism as a system PATIENT 1: Seven-year old female with a history of normal development until age two. At this point she developed episodic vomiting, acidosis, epilepsy, general weakness, ataxia

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Epileptic encephalopathy, early infantile 4. OMIM number for disease 612164 Disease

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Leber congenital amaurosis OMIM number for disease 204000 Disease alternative

More information

SEX-LINKED INHERITANCE. Dr Rasime Kalkan

SEX-LINKED INHERITANCE. Dr Rasime Kalkan SEX-LINKED INHERITANCE Dr Rasime Kalkan Human Karyotype Picture of Human Chromosomes 22 Autosomes and 2 Sex Chromosomes Autosomal vs. Sex-Linked Traits can be either: Autosomal: traits (genes) are located

More information

2/18/ yo man with history of mild developmental delay and chorea of unclear etiology, with new complaints of speech difficulty

2/18/ yo man with history of mild developmental delay and chorea of unclear etiology, with new complaints of speech difficulty 18 yo man with history of mild developmental delay and chorea of unclear etiology, with new complaints of speech difficulty Audrey Foster-Barber UCSF Child Neurology February 18, 2011 Several years of

More information

Case presentations from diagnostic exome sequencing results in ion channels M. Koko, U. Hedrich, H. Lerche DASNE meeting 2017, Eisenach

Case presentations from diagnostic exome sequencing results in ion channels M. Koko, U. Hedrich, H. Lerche DASNE meeting 2017, Eisenach Case presentations from diagnostic exome sequencing results in ion channels M. Koko, U. Hedrich, H. Lerche DASNE meeting 2017, Eisenach CASE 1: Clinical picture Patient s presentation: 38 year old jewish

More information

Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report

Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report Roshanak Jazayeri, MD, PhD Assistant Professor of Medical Genetics Faculty of Medicine, Alborz University of Medical Sciences

More information

Riunione Regionale SIN Campania

Riunione Regionale SIN Campania Riunione Regionale SIN Campania Dott.ssa Maria Lieto Dipartimento di Neuroscienze, Università Federico II Napoli Salerno, 14 dicembre 2018 HEREDITARY ATAXIAS SCAs (35 genes) ARCAs (94 genes) Diagnosis?

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Choroideremia OMIM number for disease 303100 Disease alternative names please

More information

Dravet syndrome : Clinical presentation, genetic investigation and anti-seizure medication. Bradley Osterman MD, FRCPC, CSCN

Dravet syndrome : Clinical presentation, genetic investigation and anti-seizure medication. Bradley Osterman MD, FRCPC, CSCN Dravet syndrome : Clinical presentation, genetic investigation and anti-seizure medication Bradley Osterman MD, FRCPC, CSCN Objectives Learn about the typical early clinical presentation of Dravet syndrome

More information

THIAMINE TRANSPORTER TYPE 2 DEFICIENCY

THIAMINE TRANSPORTER TYPE 2 DEFICIENCY THIAMINE TRANSPORTER TYPE 2 DEFICIENCY WHAT IS THE THIAMINE TRANSPORTER TYPE 2 DEFICIENCY (hthtr2)? The thiamine transporter type 2 deficiency (hthtr2) is a inborn error of thiamine metabolism caused by

More information

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University

Evolution of Genetic Testing. Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Evolution of Genetic Testing Joan Pellegrino MD Associate Professor of Pediatrics SUNY Upstate Medical University Genetic Testing Chromosomal analysis Flourescent in situ hybridization (FISH) Chromosome

More information

Supplementary Note. Patient #1 Additional Details

Supplementary Note. Patient #1 Additional Details Supplementary Note Patient #1 Additional Details Past medical history: The patient was ambidextrous. She had a history of hypertension, hyperlipidemia, migraines, and remote history of an ANA-positive

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Parkinson disease 8, automsomal dominant OMIM number for disease 607060 Disease

More information

DISORDERS OF THE MOTOR SYSTEM. Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine

DISORDERS OF THE MOTOR SYSTEM. Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine DISORDERS OF THE MOTOR SYSTEM Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine THE MOTOR SYSTEM To understand disorders of the motor system, we need to review how a

More information

Clinical and Regulatory Challenges in Developing New Treatments for Rare Diseases

Clinical and Regulatory Challenges in Developing New Treatments for Rare Diseases Clinical and Regulatory Challenges in Developing New Treatments for Rare Diseases R. Anand, M.D. APC AG, Switzerland ISCTM, Washington DC February 20 th, 2018 Conflict of Interests A - Z Too many to mention

More information

Movement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types

Movement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types Background Movement Disorders Psychology 372 Physiological Psychology Steven E. Meier, Ph.D. Listen to the audio lecture while viewing these slides Early Studies Found some patients with progressive weakness

More information

CITATION FILE CONTENT/FORMAT

CITATION FILE CONTENT/FORMAT CITATION For any resultant publications using please cite: Matthew A. Field, Vicky Cho, T. Daniel Andrews, and Chris C. Goodnow (2015). "Reliably detecting clinically important variants requires both combined

More information

The Genetics of VHL. Proper tissue growth - controlled traffic. How human cells and tissue grow and die?

The Genetics of VHL. Proper tissue growth - controlled traffic. How human cells and tissue grow and die? How human cells and tissue grow and die? The Genetics of VHL Xia Wang MD PhD Oct, 2017 Proper tissue growth - controlled traffic Normal tissue growth is regulated by many genetic factors Safe traffic is

More information

Genotypic and phenotypic overlaps in Parkinson s disease and parkinsonisms

Genotypic and phenotypic overlaps in Parkinson s disease and parkinsonisms Genotypic and phenotypic overlaps in Parkinson s disease and parkinsonisms Enza Maria Valente CSS-Mendel Institute, Rome University of Salerno The «shaking palsy»: clinica features Involuntary tremulous

More information

Title:Exome sequencing helped the fine diagnosis of two siblings afflicted with atypical Timothy syndrome (TS2)

Title:Exome sequencing helped the fine diagnosis of two siblings afflicted with atypical Timothy syndrome (TS2) Author's response to reviews Title:Exome sequencing helped the fine diagnosis of two siblings afflicted with atypical Timothy syndrome (TS2) Authors: Sebastian Fröhler (Sebastian.Froehler@mdc-berlin.de)

More information

Clinical utility of the functional mrna evaluation of rare genetic variants in diagnostic practice

Clinical utility of the functional mrna evaluation of rare genetic variants in diagnostic practice Clinical utility of the functional mrna evaluation of rare genetic variants in diagnostic practice Celia Duff-Farrier: STP MSc project 2017 Funding provided by the Showering Fund mrna functional evaluation

More information

Dizziness, postural hypotension and postural blackouts: Two cases suggesting multiple system atrophy

Dizziness, postural hypotension and postural blackouts: Two cases suggesting multiple system atrophy Dizziness, postural hypotension and postural blackouts: Two cases suggesting multiple system atrophy Dr Rahul Chakor, Associate Prof and Head Dept of Neurology, Dr Anand Soni, Senior Resident, T N Medical

More information

GENOTYPE-PHENOTYPE CORRELATIONS IN GALACTOSEMIA COMPLICATIONS COMPLICATIONS COMPLICATIONS LONG-TERM CHRONIC COMPLICATIONS WITH NO CLEAR CAUSE

GENOTYPE-PHENOTYPE CORRELATIONS IN GALACTOSEMIA COMPLICATIONS COMPLICATIONS COMPLICATIONS LONG-TERM CHRONIC COMPLICATIONS WITH NO CLEAR CAUSE Galactosemia Deficiency: galactose-1-phosphate-uridyltransferase(galt) GENOTYPE-PHENOTYPE CORRELATIONS IN GALACTOSEMIA GALT D-galactose-1-phosphate UDPgalactose + + UDPglucose D-glucose-1-phosphate DIVISION

More information

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi 2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000

More information

Presentation and investigation of mitochondrial disease in children

Presentation and investigation of mitochondrial disease in children Presentation and investigation of mitochondrial disease in children Andrew Morris Willink Unit, Manchester Mitochondrial function Carbohydrate Fat Respiratory chain Energy Mitochondria are the product

More information

LUXTURNA (voretigene neparovec-rzyl)

LUXTURNA (voretigene neparovec-rzyl) LUXTURNA (voretigene neparovec-rzyl) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical

More information

Human Genetic Diseases (non mutation)

Human Genetic Diseases (non mutation) mutation) Pedigrees mutation) 1. Autosomal recessive inheritance: this is the inheritance of a disease through a recessive allele. In order for the person to have the condition they would have to be homozygous

More information

Beta Propeller Protein Associated Neurodegeneration (BPAN) Treatment with Iron Chelation Therapy

Beta Propeller Protein Associated Neurodegeneration (BPAN) Treatment with Iron Chelation Therapy Title: Type of Manuscript: Running Title: A Patient with Beta Propeller Protein Associated Neurodegeneration (BPAN): Treatment with Iron Chelation Therapy Case Reports Beta Propeller Protein Associated

More information

2. A normal human germ cell before meiosis has how many nuclear chromosomes?

2. A normal human germ cell before meiosis has how many nuclear chromosomes? 1 Lesson 5 Transmission/Heredity 1. Each of the following pedigrees represent one of the major modes of inheritance that we learned about for a dominant trait: (1) Autosomal, (2) Sex linked, or (3) Maternal.

More information

Chapter 1 : Genetics 101

Chapter 1 : Genetics 101 Chapter 1 : Genetics 101 Understanding the underlying concepts of human genetics and the role of genes, behavior, and the environment will be important to appropriately collecting and applying genetic

More information

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our 1 2 Supplemental Data: Detailed Characteristics of Patients with MKRN3 Mutations 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Patient 1 was born after an uneventful pregnancy. She presented

More information

CN V! touch! pain! Touch! P/T!

CN V! touch! pain! Touch! P/T! CN V! touch! pain! Touch! P/T! Visual Pathways! L! R! B! A! C! D! LT! E! F! RT! G! hypothalamospinal! and! ALS! Vestibular Pathways! 1. Posture/Balance!!falling! 2. Head Position! 3. Eye-Head Movements

More information

Identifying Mutations Responsible for Rare Disorders Using New Technologies

Identifying Mutations Responsible for Rare Disorders Using New Technologies Identifying Mutations Responsible for Rare Disorders Using New Technologies Jacek Majewski, Department of Human Genetics, McGill University, Montreal, QC Canada Mendelian Diseases Clear mode of inheritance

More information

1 in 68 in US. Autism Update: New research, evidence-based intervention. 1 in 45 in NJ. Selected New References. Autism Prevalence CDC 2014

1 in 68 in US. Autism Update: New research, evidence-based intervention. 1 in 45 in NJ. Selected New References. Autism Prevalence CDC 2014 Autism Update: New research, evidence-based intervention Martha S. Burns, Ph.D. Joint Appointment Professor Northwestern University. 1 Selected New References Bourgeron, Thomas (2015) From the genetic

More information

MNGenome Sequencing Test Request Form

MNGenome Sequencing Test Request Form MNGenome Sequencing Test Request Form Whole Whole Genome Exome Sequencing Note: Clinical Information and Consent Form are required for MNGenome Orders. *Please note if samples are shipping separately as

More information

p.arg119gly p.arg119his p.ala179thr c.540+1g>a c.617_633+6del Prediction basis structure

p.arg119gly p.arg119his p.ala179thr c.540+1g>a c.617_633+6del Prediction basis structure a Missense ATG p.arg119gly p.arg119his p.ala179thr p.ala189val p.gly206trp p.gly206arg p.arg251his p.ala257thr TGA 5 UTR 1 2 3 4 5 6 7 3 UTR Splice Site, Frameshift b Mutation p.gly206trp p.gly4fsx50 c.138+1g>a

More information

Orofacial function of persons having. Report from questionnaires. Salla disease

Orofacial function of persons having. Report from questionnaires. Salla disease 7-- Orofacial function of persons having Salla disease Report from questionnaires The survey comprises questionnaires. Synonyms: Sialic acid storage disorder, SIASD, Sialuria Finnish type. Estimated occurrence:

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider TEST DISORDER/CONDITION POPULATION TRIAD Submitting laboratory: Exeter RGC Approved: Sept 2013 1. Disorder/condition

More information

Update on the Genetics of Ataxia. Vicki Wheelock MD UC Davis Department of Neurology GHPP Clinic

Update on the Genetics of Ataxia. Vicki Wheelock MD UC Davis Department of Neurology GHPP Clinic Update on the Genetics of Ataxia Vicki Wheelock MD UC Davis Department of Neurology GHPP Clinic Outline Definitions Review of genetics Autosomal Dominant cerebellar ataxias Autosomal Recessive cerebellar

More information

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Gordon Blackshields Senior Bioinformatician Source BioScience 1 To Cancer Genetics Studies

More information

Patient L.L. KRISTEN ARREDONDO, MD CHILD NEUROLOGY PGY5, UT SOUTHWESTERN

Patient L.L. KRISTEN ARREDONDO, MD CHILD NEUROLOGY PGY5, UT SOUTHWESTERN Patient L.L. KRISTEN ARREDONDO, MD CHILD NEUROLOGY PGY5, UT SOUTHWESTERN Birth History LL was born to a healthy first time mother with an uncomplicated pregnancy Delivered at 38 weeks via C-section due

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Choi YL, Soda M, Yamashita Y, et al. EML4-ALK mutations in

More information

Exploding Genetic Knowledge in Developmental Disabilities. Disclosures. The Genetic Principle

Exploding Genetic Knowledge in Developmental Disabilities. Disclosures. The Genetic Principle Exploding Genetic Knowledge in Developmental Disabilities How to acquire the data and how to make use of it Elliott H. Sherr MD PhD Professor of Neurology & Pediatrics UCSF Disclosures InVitae: clinical

More information

Multiple System Atrophy

Multiple System Atrophy Multiple System Atrophy This document has been prepared to help you become more informed about Multiple System Atrophy. It is designed to answer questions about the condition and includes suggestions on

More information

Medical Advisory Council: Verified

Medical Advisory Council: Verified What is White Sutton Syndrome? White Sutton Syndrome (WHSUS) is a condition characterized by autism and developmental delay and/or intellectual disability, as well as a characteristic facial profile. Children

More information

Genome 371, Autumn 2018 Quiz Section 9: Genetics of Cancer Worksheet

Genome 371, Autumn 2018 Quiz Section 9: Genetics of Cancer Worksheet Genome 371, Autumn 2018 Quiz Section 9: Genetics of Cancer Worksheet All cancer is due to genetic mutations. However, in cancer that clusters in families (familial cancer) at least one of these mutations

More information

SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA)

SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA) DEFICIENCY OF METABOLITE -HYPOXIA AND HYPOGLYCEMIA -HYPOVITAMINOSIS SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA) -SPECIFIC CELL TYPE NEURONS>OLIGODENDROCYTES>ASTROCYTES -SPECIFIC BRAIN REGION PYRAMIDAL

More information

CHAPTER IV RESULTS. The goal of this study was to identify the underlying genetic defect in patients with MR

CHAPTER IV RESULTS. The goal of this study was to identify the underlying genetic defect in patients with MR CHAPTER IV RESULTS The goal of this study was to identify the underlying genetic defect in patients with MR and epilepsy. Mutation analysis from the syndromic patients were performed, from the non syndromic

More information

VL VA BASAL GANGLIA. FUNCTIONAl COMPONENTS. Function Component Deficits Start/initiation Basal Ganglia Spontan movements

VL VA BASAL GANGLIA. FUNCTIONAl COMPONENTS. Function Component Deficits Start/initiation Basal Ganglia Spontan movements BASAL GANGLIA Chris Cohan, Ph.D. Dept. of Pathology/Anat Sci University at Buffalo I) Overview How do Basal Ganglia affect movement Basal ganglia enhance cortical motor activity and facilitate movement.

More information

Fatty Acids Synthesis L3

Fatty Acids Synthesis L3 Fatty Acids Synthesis L3 The pathway for fatty acid synthesis occurs in the cytoplasm, whereas, oxidation occurs in the mitochondria. The other major difference is the use of nucleotide co-factors. Oxidation

More information

Figure e-1 (A) Visualization of mapping results of exome sequencing of patient 10 by Integrative Genomics Viewer. The location of a mosaic mutation

Figure e-1 (A) Visualization of mapping results of exome sequencing of patient 10 by Integrative Genomics Viewer. The location of a mosaic mutation Figure e-1 (A) Visualization of mapping results of exome sequencing of patient 10 by Integrative Genomics Viewer. The location of a mosaic mutation (c.3976g>c) is indicated by an arrow. Exome sequencing

More information

Exploring hereditary ataxia and spasticity in the era of whole exome sequencing

Exploring hereditary ataxia and spasticity in the era of whole exome sequencing Universiteit Antwerpen Faculteit Geneeskunde en Gezondheidswetenschappen Exploring hereditary ataxia and spasticity in the era of whole exome sequencing Proefschrift voorgelegd tot het behalen van de graad

More information

10/13/2017. Disclosures. Deep Brain Stimulation in the Treatment of Movement Disorders. Deep Brain Stimulation: Objectives.

10/13/2017. Disclosures. Deep Brain Stimulation in the Treatment of Movement Disorders. Deep Brain Stimulation: Objectives. Deep Brain Stimulation in the Treatment of Movement Disorders Disclosures None Eleanor K Orehek, M.D. Movement Disorders Specialist Noran Neurological Clinic 1 2 Objectives To provide an overview of deep

More information

Juvenile-onset Huntington s disease

Juvenile-onset Huntington s disease Juvenile-onset Huntington s disease Presenter Disclosures Martha A. Nance MD The following personal financial relationships with commercial interests relevant to this presentation existed during the past

More information

CANCER GENETICS PROVIDER SURVEY

CANCER GENETICS PROVIDER SURVEY Dear Participant, Previously you agreed to participate in an evaluation of an education program we developed for primary care providers on the topic of cancer genetics. This is an IRB-approved, CDCfunded

More information

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018 Neurodegenerative disorders: an approach to investigation Robert Robinson Practical Paediatric Neurology Study Days April 2018 Aims An approach to investigating and diagnosing young children with progressive

More information

BWA alignment to reference transcriptome and genome. Convert transcriptome mappings back to genome space

BWA alignment to reference transcriptome and genome. Convert transcriptome mappings back to genome space Whole genome sequencing Whole exome sequencing BWA alignment to reference transcriptome and genome Convert transcriptome mappings back to genome space genomes Filter on MQ, distance, Cigar string Annotate

More information

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) A Neurosurgical Treatment for Parkinson s Disease Parkinson s Disease Parkinson s disease is a common neurodegenerative disorder that affects about

More information

Egypt 90 Million People Power Seven Thousands Year Culture 29 Governorates

Egypt 90 Million People Power Seven Thousands Year Culture 29 Governorates Egypt 90 Million People Power Seven Thousands Year Culture 29 Governorates Recent advances in Molecular Medicine: Changing the practice of neurology Presentation by Nagwa Meguid, Prof. of Human Genetics

More information

Lecture XIII. Brain Diseases I - Parkinsonism! Brain Diseases I!

Lecture XIII. Brain Diseases I - Parkinsonism! Brain Diseases I! Lecture XIII. Brain Diseases I - Parkinsonism! Bio 3411! Wednesday!! Lecture XIII. Brain Diseases - I.! 1! Brain Diseases I! NEUROSCIENCE 5 th ed! Page!!Figure!!Feature! 408 18.9 A!!Substantia Nigra in

More information

Hereditary spastic paraplegia Report from questionnaires

Hereditary spastic paraplegia Report from questionnaires Orofacial function of persons having Hereditary spastic paraplegia Report from questionnaires The survey comprises 6 questionnaires. Synonyms: Hereditary Spastic Paraplegia, Strumpell-Lorraine Syndrome

More information

Huntington s Disease and HD-like Disorders Prof. Sarah Tabrizi MD PhD FMedSci

Huntington s Disease and HD-like Disorders Prof. Sarah Tabrizi MD PhD FMedSci Huntington s Disease and HD-like Disorders UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery Queen Square London 1 Genetic causes of chorea: HD and HD-like disorders (HD phenocopies)

More information

The Promise of Epilepsy Genetics A Personal & Scientific Perspective December 3, 2012

The Promise of Epilepsy Genetics A Personal & Scientific Perspective December 3, 2012 The Promise of Epilepsy Genetics A Personal & Scientific Perspective December 3, 2012 Tracy Dixon-Salazar, Ph.D. University of California, San Diego American Epilepsy Society Annual Meeting 1 Disclosure

More information

Neuroradiological, clinical and genetic characterization of new forms of hereditary leukoencephalopathies

Neuroradiological, clinical and genetic characterization of new forms of hereditary leukoencephalopathies Neuroradiological, clinical and genetic characterization of new forms of hereditary leukoencephalopathies Principal Investigator: Dr. Donatella Tampieri, MD, FRCPC, Department of Neuroradiology, Montreal

More information

Novel Heterozygous Mutation in YAP1 in A Family with Isolated Ocular Colobomas

Novel Heterozygous Mutation in YAP1 in A Family with Isolated Ocular Colobomas Novel Heterozygous Mutation in YAP1 in A Family with Isolated Ocular Colobomas Julius T. Oatts 1, Sarah Hull 2, Michel Michaelides 2, Gavin Arno 2, Andrew R. Webster 2*, Anthony T. Moore 1,2* 1. Department

More information

What is Alport s Syndrome? Why it is called Alport s Syndrome? What Causes Alport s Syndrome, and differences between men and women?

What is Alport s Syndrome? Why it is called Alport s Syndrome? What Causes Alport s Syndrome, and differences between men and women? ALPORT S SYNDROME What is Alport s Syndrome? Why is it called Alport s Syndrome? What causes Alport s Syndrome? How is Alport s Syndrome diagnosed? Is Alport s Syndrome common? Is there any treatment to

More information

Problem Set 5 KEY

Problem Set 5 KEY 2006 7.012 Problem Set 5 KEY ** Due before 5 PM on THURSDAY, November 9, 2006. ** Turn answers in to the box outside of 68-120. PLEASE WRITE YOUR ANSWERS ON THIS PRINTOUT. 1. You are studying the development

More information

Supporting Online Material for

Supporting Online Material for www.sciencemag.org/cgi/content/full/1171320/dc1 Supporting Online Material for A Frazzled/DCC-Dependent Transcriptional Switch Regulates Midline Axon Guidance Long Yang, David S. Garbe, Greg J. Bashaw*

More information

Efficient Feature Extraction and Classification Methods in Neural Interfaces

Efficient Feature Extraction and Classification Methods in Neural Interfaces Efficient Feature Extraction and Classification Methods in Neural Interfaces Azita Emami Professor of Electrical Engineering and Medical Engineering Next Generation Therapeutic Devices 2 Where We Started:

More information

epileptic encephalopathy as the initial clinical presentation of WDR45 deletion in a male patient.

epileptic encephalopathy as the initial clinical presentation of WDR45 deletion in a male patient. Early-onset epileptic encephalopathy as the initial clinical presentation of WDR45 deletion in a male patient Affef Abidi, Cecile Mignon-Ravix, Pierre Cacciagli, Nadine Girard, Mathieu Milh, Laurent Villard

More information

Disclosure. Agenda. I do not have any relevant financial/non financial relationships with any proprietary interests

Disclosure. Agenda. I do not have any relevant financial/non financial relationships with any proprietary interests Luis Rohena, MD Chief, Medical Genetics San Antonio Military Medical Center Assistant Professor of Pediatrics USUHS & UTHSCSA 15JUNE2014 51st Annual Teaching Conference Pediatrics for the Practitioner

More information

GENDER James Bier

GENDER James Bier GENDER 2005-2008 James Bier Objectives 1. State the method of determining gender in several genetic systems. 2. List the three regions of the Y chromosome. 3. Describe the events that promote sexual development

More information

Središnja medicinska knjižnica

Središnja medicinska knjižnica Središnja medicinska knjižnica Maradin, M., Fumić, K., Hansikova, H., Tesarova, M., Wenchich, L., Dorner, S., Sarnavka, V., Zeman, J., Barić, I. (2006) Fumaric aciduria: Mild phenotype in a 8-year-old

More information

MAXIMIZING FUNCTION IN PARKINSON S DISEASE

MAXIMIZING FUNCTION IN PARKINSON S DISEASE 1 MAXIMIZING FUNCTION IN PARKINSON S DISEASE September 13, 2016 End Falls This Falls Conference Jan Goldstein Elman One Step Ahead Mobility Toronto, Ontario Outline An overview of Parkinson s disease (PD):

More information

Dystonia. The condition can vary from very mild to severe. Dystonia may get worse over time or it may stay the same or get better.

Dystonia. The condition can vary from very mild to severe. Dystonia may get worse over time or it may stay the same or get better. Dystonia What are movement disorders? Movement disorders are conditions that cause involuntary body movements. With all movement disorders, abnormal signals from the brain cause patients to have trouble

More information

ACTH therapy for generalized seizures other than spasms

ACTH therapy for generalized seizures other than spasms Seizure (2006) 15, 469 475 www.elsevier.com/locate/yseiz ACTH therapy for generalized seizures other than spasms Akihisa Okumura a,b, *, Takeshi Tsuji b, Toru Kato b, Jun Natsume b, Tamiko Negoro b, Kazuyoshi

More information

MOLECULAR DIAGNOSIS for X-LINKED INTELLECTUAL DISABILITY

MOLECULAR DIAGNOSIS for X-LINKED INTELLECTUAL DISABILITY MOLECULAR DIAGNOSIS for X-LINKED INTELLECTUAL DISABILITY Intellectual disability (ID) or mental retardation is characterized by significant limitations in cognitive abilities and social/behavioral adaptive

More information

SURVEY OF DUCHENNE TYPE AND CONGENITAL TYPE OF MUSCULAR DYSTROPHY IN SHIMANE, JAPAN 1

SURVEY OF DUCHENNE TYPE AND CONGENITAL TYPE OF MUSCULAR DYSTROPHY IN SHIMANE, JAPAN 1 Jap. J. Human Genet. 22, 43--47, 1977 SURVEY OF DUCHENNE TYPE AND CONGENITAL TYPE OF MUSCULAR DYSTROPHY IN SHIMANE, JAPAN 1 Kenzo TAKESHITA,* Kunio YOSHINO,* Tadashi KITAHARA,* Toshio NAKASHIMA,** and

More information

NGS. Search for homozygous regions. Why is there a need for a new diagnostic tool? Department of Genetics and Metabolic Diseases Hadassah, Jerusalem

NGS. Search for homozygous regions. Why is there a need for a new diagnostic tool? Department of Genetics and Metabolic Diseases Hadassah, Jerusalem Why is there a need for a new diagnostic tool? Homozygosity mapping as a primary, new diagnostic tool ERNDIM meeting, Basel, Oct 22, 2009 Orly Elpeleg Department of Genetics and Metabolic Diseases Hadassah,

More information

SUPPLEMENTARY INFORMATION. Rett Syndrome Mutation MeCP2 T158A Disrupts DNA Binding, Protein Stability and ERP Responses

SUPPLEMENTARY INFORMATION. Rett Syndrome Mutation MeCP2 T158A Disrupts DNA Binding, Protein Stability and ERP Responses SUPPLEMENTARY INFORMATION Rett Syndrome Mutation T158A Disrupts DNA Binding, Protein Stability and ERP Responses Darren Goffin, Megan Allen, Le Zhang, Maria Amorim, I-Ting Judy Wang, Arith-Ruth S. Reyes,

More information

Supplementary Figure 1. Schematic diagram of o2n-seq. Double-stranded DNA was sheared, end-repaired, and underwent A-tailing by standard protocols.

Supplementary Figure 1. Schematic diagram of o2n-seq. Double-stranded DNA was sheared, end-repaired, and underwent A-tailing by standard protocols. Supplementary Figure 1. Schematic diagram of o2n-seq. Double-stranded DNA was sheared, end-repaired, and underwent A-tailing by standard protocols. A-tailed DNA was ligated to T-tailed dutp adapters, circularized

More information

A. Incorrect! Cells contain the units of genetic they are not the unit of heredity.

A. Incorrect! Cells contain the units of genetic they are not the unit of heredity. MCAT Biology Problem Drill PS07: Mendelian Genetics Question No. 1 of 10 Question 1. The smallest unit of heredity is. Question #01 (A) Cell (B) Gene (C) Chromosome (D) Allele Cells contain the units of

More information

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)

More information